Comparison of two alternative sequences with cabazitaxel and 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: A retrospective multicenter study (LuCaS)

已完结 10 由洋葱土豆发布于 2025/12/23 14:38:45

DOI:10.1016/j.ejca.2025.115226
作者：Hatice Bolek ,?Sat? Coskun Yazgan ,?Furkan Ceylan ,?Jorge Esteban-Villarrubia ,?Cagatay Arslan ,?Tülay Ku? ,?Deniz Tural ,?Mehmet Ali Nahit Sendur ,?Nuriye Ozlem Kucuk ,?Elif ??ng? ?zdemir ,?Elena Ca
文献类型：期刊论文
补充材料：只需要正文

Elsevier

Abstract：BackgroundCabazitaxel and 177Lu-PSMA-617 have been shown to improve survival in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel and an

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:ElsevierHigh-throughput BiOBr/TpPa-1 PVDF membrane with exceptional photodegradation efficiency for dye wastewater treatment